Burrill & Company CEO G. Steven Burrill Featured in Ernst & Young's Connect

December 23, 2011

› Learn more

Biotech Visionary G. Steven Burrill Offers Predictions on 2012

December 21, 2011

› Learn more

Burrill & Company Announces Initiation of Burrill Capital Fund IV, L.P. Operations

December 18, 2011

› Learn more

Burrill & Company Advises Samsung in Biosimilars Joint Venture Agreement with Biogen Idec

December 06, 2011

› Learn more

Biotech Sector Scores Wins in November Despite Global Economic Turmoil

December 01, 2011

› Learn more

Gilead to acquire Burrill portfolio company Pharmasset for $11 billion

November 28, 2011

› Learn more

Biotech Visionary G. Steven Burrill Honored With Breath of Life Award From the Northern California Chapter of the Cystic Fibrosis Foundation

November 14, 2011

› Learn more

Biotech Visionary G. Steven Burrill Honored with Scrip Lifetime Achievement Award

November 03, 2011

› Learn more

Ongoing Market Volatility Dampens Public Financings for Biotech

November 01, 2011

› Learn more

Debt Worries, Political Dysfunction Take a Toll on Biotech in Third Quarter

Biotech stocks fall with the market as financing activity slows

October 03, 2011

› Learn more

Promise of Personalized Medicine Remains Unrealized

Burrill & Company Meeting Explores the Challenges Faced by the Drugs, Tools, and Diagnostics Companies Leading a Revolution in Healthcare

September 15, 2011

› Learn more

Volatile Markets in August Take a Toll on Life Sciences IPOs

Burrill & Company says poor performance for new issues, depressed stocks, could fuel surge in M&A

August 31, 2011

› Learn more

New Drug Approvals in 2011 Already Match 2010 Total

Burrill & Company sees environment improving for life sciences, but macroeconomic threats persist.

July 31, 2011

› Learn more

Biotech Posts Strong Second Quarter Gain

July 04, 2011

› Learn more

Big Oil and Emerging Biofuels Developers Forge Marriage of Convenience

June 14, 2011

› Learn more

Burrill & Company Appoints New Head of Its Merchant Banking Group and Augments Its Group

June 06, 2011

› Learn more

Burrill & Company Adds to Its Alternative Equities Group

June 03, 2011

› Learn more

Biotech posts small gain in May

June 02, 2011

› Learn more

Life Sciences Executives, Policymakers Gather to Discuss Emerging Opportunities in Pan-Asian Markets at Burrill & Company Meeting

May 26, 2011

› Learn more

Novadaq Announces Appointment of G. Steven Burrill to Its Board of Directors

May 24, 2011

› Learn more

Fight Over User Fees Underscores Bigger Questions About FDA's Mission and Relationship With the Companies It Regulates, Burrill & Company Report Finds

May 19, 2011

› Learn more

Meet Top Biotech Executives at The Burrill Latin America Life Sciences, May 19-20 in Rio

May 17, 2011

› Learn more

Biotech posts strong performance in April

May 03, 2011

› Learn more

Robust Latin America economies encouraging investment, especially in healthcare

April 27, 2011

› Learn more

Latin America will benefit from biofuels boom

April 25, 2011

› Learn more

M&A Has Failed to Build Value for Pharma, Burrill Annual Biotech Report Finds

Pressure to Find Better Models to Discover and Develop New Drugs Increases

April 12, 2011

› Learn more

Biotech posts strong first quarter gain

April 05, 2011

› Learn more

G. Steven Burill Discusses His New Book Biotech 2011-Life Sciences: Looking Back to See Ahead

March 24, 2011

› Learn more

Big Pharma's Woes Are an Opportunity for Biotech

March 22, 2011

› Learn more

Boom Times for Genomics Startups

Investment is picking up as sales of gene sequencing machines surge

March 17, 2011

› Learn more

Dirk Lammerts joins Burrill Venture Capital Group

Focus will be on building the company’s activities in digital health

March 10, 2011

› Learn more

Biotech picks up momentum in February

March 03, 2011

› Learn more

Biotech begins year on a quiet, but optimistic note

February 01, 2011

› Learn more

Biotech closes out the year on a high

January 03, 2011

› Learn more